The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.

Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the ...

Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring ...

The Dow Jones Industrial Average (DJI) is down more than 131 points this afternoon, while the Nasdaq Composite (IXIC) and S&P 500 Index (SPX) are trading slightly below breakeven amid mixed messages ...

Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis.

Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 ...

MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.